The use of transcription factors only, ASCL1, NURR1, and LMX1A, to directly convert fibroblasts of healthy and Parkinson’s disease (PD) patients into dopaminergic cells is possible but with limited efficiency in human cells (Caiazzo et al., 2011). The gene discussed is NR4A2; the disease is Parkinson disease.